Clinical Trials
13
Active:2
Completed:7
Trial Phases
1 Phases
Not Applicable:13
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Not Applicable
13 (100.0%)Airway Data Collection With the Entarik Feeding Tube System
Not Applicable
Recruiting
- Conditions
- Healthy
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Theranova, L.L.C.
- Target Recruit Count
- 30
- Registration Number
- NCT06760572
- Locations
- 🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States
EMPOWER AUD Pivotal Trial
Not Applicable
Active, not recruiting
- Conditions
- AlcoholismAlcohol Use DisorderAlcohol Abuse
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Theranova, L.L.C.
- Target Recruit Count
- 128
- Registration Number
- NCT05948605
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸Yale University, New Haven, Connecticut, United States
Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms
Not Applicable
Completed
- Conditions
- Overactive Bladder
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Theranova, L.L.C.
- Target Recruit Count
- 3
- Registration Number
- NCT05162833
- Locations
- 🇺🇸
UC Davis Health, Sacramento, California, United States
🇺🇸Stanford University Medical Center, Stanford, California, United States
Empower Neuromodulation System - Pilot Study for Anxiety Treatment
Not Applicable
Terminated
- Conditions
- Generalized Anxiety Disorder
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Theranova, L.L.C.
- Target Recruit Count
- 18
- Registration Number
- NCT04901481
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms
Not Applicable
Completed
- Conditions
- Overactive Bladder
- First Posted Date
- 2021-02-17
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Theranova, L.L.C.
- Target Recruit Count
- 12
- Registration Number
- NCT04758247
- Locations
- 🇺🇸
UC Davis Health, Sacramento, California, United States
🇺🇸Stanford Medicine, Stanford, California, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found